|
1. Biologie
|
|
|
A fuller picture of cancer [Harvard Gazette]
|
|
|
|
|
|
“This
migration ability helps to explain how driver mutations are able to
dominate a tumor, and also explains why targeted therapies fail within a
few months as resistance evolves,” Nowak said. “So what we have is a
mathematical model for solid tumors, and it’s this local migration that
explains these questions.”
|
|
|
|
|
|
|
3.1 Tabac
|
|
|
|
|
4. Dépistage, diagnostic et pronostic
|
|
|
|
4.9 Dép., diag. & prono. - Sein
|
|
|
|
5. Traitements
|
|
|
|
5.2 Pharma
|
|
|
In New York, Rgenix Rises From Rockefeller and Takes Aim at Cancer [Xconomy]
|
|
|
|
|
|
Importantly,
Tavazoie notes, activating APOE, RGX-104 spurs on the innate immune
system to fight cancer. That’s the body’s first line of defense, and an
arm of the immune system that the “checkpoint inhibitor” cancer drugs
like pembrolizumab (Keytruda) and nivolumab (Opdivo)—which have started
to completely change cancer care—don’t impact.
|
|
|
|
|
|
|
5.2.1 Pharma - Partenariats
|
|
|
|
6. Lutte contre les cancers
|
|
|
|
|
6.7 DMP, Big Data & applis
|
|
|